ArticleClinical pharmacokinetics2017
Pharmacokinetics and Tolerability of Anti-Hepatitis C Virus Treatment with Ombitasvir, Paritaprevir, Ritonavir, with or Without Dasabuvir, in Subjects with Renal Impairment.
Amit Khatri et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papertrialcites it